SE9803272D0 - A drug for cell regeneration - Google Patents

A drug for cell regeneration

Info

Publication number
SE9803272D0
SE9803272D0 SE9803272A SE9803272A SE9803272D0 SE 9803272 D0 SE9803272 D0 SE 9803272D0 SE 9803272 A SE9803272 A SE 9803272A SE 9803272 A SE9803272 A SE 9803272A SE 9803272 D0 SE9803272 D0 SE 9803272D0
Authority
SE
Sweden
Prior art keywords
cell regeneration
drug
order
relates
improve cell
Prior art date
Application number
SE9803272A
Other languages
English (en)
Inventor
Kerstin Uvnaes-Moberg
Thomas Lundeberg
Original Assignee
Kerstin Uvnaes Moberg
Thomas Lundeberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kerstin Uvnaes Moberg, Thomas Lundeberg filed Critical Kerstin Uvnaes Moberg
Priority to SE9803272A priority Critical patent/SE9803272D0/sv
Publication of SE9803272D0 publication Critical patent/SE9803272D0/sv
Priority to EP99952872A priority patent/EP1115416B1/en
Priority to DE69937959T priority patent/DE69937959D1/de
Priority to AT99952872T priority patent/ATE383166T1/de
Priority to JP2000571941A priority patent/JP2002525337A/ja
Priority to PCT/SE1999/001713 priority patent/WO2000018424A1/en
Priority to AU64931/99A priority patent/AU6493199A/en
Priority to CN99812672A priority patent/CN1330550A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
SE9803272A 1998-09-25 1998-09-25 A drug for cell regeneration SE9803272D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9803272A SE9803272D0 (sv) 1998-09-25 1998-09-25 A drug for cell regeneration
EP99952872A EP1115416B1 (en) 1998-09-25 1999-09-27 Use of substances with oxytocin activity in order to create cell regeneration
DE69937959T DE69937959D1 (de) 1998-09-25 1999-09-27 Verwendung von substanzen mit oxytocin aktivität mit dem ziel der zellregeneration
AT99952872T ATE383166T1 (de) 1998-09-25 1999-09-27 Verwendung von substanzen mit oxytocin aktivität mit dem ziel der zellregeneration
JP2000571941A JP2002525337A (ja) 1998-09-25 1999-09-27 細胞再生をもたらすオキシトシン活性物質の使用
PCT/SE1999/001713 WO2000018424A1 (en) 1998-09-25 1999-09-27 Use of substances with oxytocin activity in order to create cell regeneration
AU64931/99A AU6493199A (en) 1998-09-25 1999-09-27 Use of substances with oxytocin activity in order to create stimulate cell regeneration
CN99812672A CN1330550A (zh) 1998-09-25 1999-09-27 具有催产素活性的物质在引起细胞再生中的应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803272A SE9803272D0 (sv) 1998-09-25 1998-09-25 A drug for cell regeneration

Publications (1)

Publication Number Publication Date
SE9803272D0 true SE9803272D0 (sv) 1998-09-25

Family

ID=20412731

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803272A SE9803272D0 (sv) 1998-09-25 1998-09-25 A drug for cell regeneration

Country Status (8)

Country Link
EP (1) EP1115416B1 (sv)
JP (1) JP2002525337A (sv)
CN (1) CN1330550A (sv)
AT (1) ATE383166T1 (sv)
AU (1) AU6493199A (sv)
DE (1) DE69937959D1 (sv)
SE (1) SE9803272D0 (sv)
WO (1) WO2000018424A1 (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915625D0 (en) * 1999-07-02 1999-09-01 Cortendo Ab Method
SE0001440D0 (sv) * 2000-04-18 2000-04-18 Entretech Medical Ab A drug against climacteric disorders
SE0100684D0 (sv) * 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject-matter
SE0102185D0 (sv) * 2001-06-19 2001-06-19 Uvnaes Moberg Kerstin New subject-matter
SE0102910D0 (sv) * 2001-08-31 2001-08-31 Moberg Kerstin Uvnaes New use
EP1468690B1 (en) * 2003-03-27 2008-10-08 Pantarhei Bioscience B.V. Use of estrogens for the treatment of infertility in male mammals
SE536091C2 (sv) 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
DE102011118016A1 (de) * 2011-10-26 2013-05-02 Henkel Ag & Co. Kgaa Kosmetische Mittel enthaltend Oxytocin und Riechstoffe
RU2544462C1 (ru) * 2013-11-29 2015-03-20 Федеральное государственное бюджетное учреждение "Государственный научный центр Российской Федерации-Федеральный медицинский биофизический центр имени А.И. Бурназяна Федерального медико-биологического агентства" (ФГБУ "ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА России") Способ профилактики развития острого панкреатита после операций на органах брюшной полости
WO2019060962A1 (en) * 2017-09-28 2019-04-04 The University Of Sydney SELECTIVE AGONISTS OF THE OCYTOCIN RECEPTOR, INSPIRED BY METABOLITES
JP7103886B2 (ja) * 2017-12-14 2022-07-20 花王株式会社 肌の質感改善剤の探索方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4312913A1 (de) * 1992-10-23 1994-10-13 Knauf Siegfried Medikamentenzusammensetzung Oxytocin, Vasopressin und alphabetagamma-Endorphine
DE4236293A1 (en) * 1992-10-23 1993-03-04 Siegfried Knauf Use of oxytocin, vasopressin and endorphins - for treatment and prevention of e.g. immunological, neurological and organ diseases and conditions caused by pituitary disorder
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II

Also Published As

Publication number Publication date
CN1330550A (zh) 2002-01-09
AU6493199A (en) 2000-04-17
JP2002525337A (ja) 2002-08-13
DE69937959D1 (de) 2008-02-21
ATE383166T1 (de) 2008-01-15
EP1115416B1 (en) 2008-01-09
EP1115416A1 (en) 2001-07-18
WO2000018424A1 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
NO981638L (no) Legemiddel- avgivelsesanordning for to eller flere aktive forbindelser
BR9807848B1 (pt) Composto de arilsulfonamidas e análogos, bem como composição farmacêutica e uso dos mesmos.
TR199902383T2 (xx) Yeni pirimidin t�revleri ve bunlar�n haz�rlanmas� i�in proses.
DE69928085D1 (de) Dosierungsform mit verlängerter wirkstoffabgabe
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
EE04450B1 (et) Farmatseutilised kompositsioonid kahe või enama toimeainega aerosoolidele
ATE312080T1 (de) 2-chinolonen enthaltende arzneimittel
FR2715847B1 (fr) Composition contenant des acides nucléiques, préparation et utilisations.
NO20011036D0 (no) Bipolar elektrode for elektrokjemiske redoks-reaksjoner
PT983995E (pt) Compostos de dimetil-(3-aril-but-3-enil)amina como substancias activas farmaceuticas
EE200000595A (et) Toimeaine viimine kandjamaatriksisse
DK1156806T3 (da) Farmaceutisk sammensætning indeholdende protonpumpeinhibitor
ATE243196T1 (de) Piperidine und pyrrolidine
SE9803272D0 (sv) A drug for cell regeneration
FR2774687B1 (fr) Lipopeptides contenant un fragment de l'interferon gamma, et leur utilisation dans des compositions pharmaceutiques
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
ES2080037T3 (es) Medicamento de uso topico con actividad cicatrizante.
EE04055B1 (et) Ühendid ja kompositsioonid seriinproteaasse, eriti trüptaasse aktiivsusega seotud haiguste raviks, ja nende kasutamine
IL139318A (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
SE0001440D0 (sv) A drug against climacteric disorders
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
SE0102910D0 (sv) New use
EA200100098A1 (ru) Соли пароксетина
ID17326A (id) Turunan-turunan asam 4-arilbutirat tersubstitusi sebagai inhibitor-inhibitor matriks metalloprotease
ATE305612T1 (de) Reporterverbindungen und verfahren zur auffindung von hochspezifische proteaseaktivität